Diane von Furstenberg Will Sell a Purse that Charges Your Phone
![Designer Diane von Furstenberg speaks to the media backstage before her Fall 2015 collection "Seduction" show at the Singapore Fashion Week](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/diane_von_verstenberg.jpg?itok=TWRQpaqK)
Fashion mogul Diane von Furstenberg said she will launch a high-tech purse that automatically—and cordlessly—charges smartphones.
The purse, which does not yet have a price tag, will go on sale in limited edition this holiday season, before rolling out broadly next year. The designer is working with an undisclosed technology partner on the handbag.
"My role in fashion is really solution driven," von Furstenberg said. "I'm always on the go, so [it's important] you have everything at the right time."
The idea of creating a handbag that charges a smartphone isn't entirely new. Kate Spade recently announced that it will launch a similar product line this fall.
Related: 16 Must-Have Products to Make Your Home Smarter Right Now
Von Furstenberg, a regular in Sun Valley, Idaho, took the stage at this year's Allen & Co. conference for a panel on the future of fashion, along with Spanx founder Sara Blakely.
She's there to meet with technology companies as she works to bring fashion into the future.
"Technology is the biggest revolution," von Furstenberg said. "It's such a big part of our lives, we do everything with technology, so it's not even separate anymore. It just is."
Related: 10 Biggest Tech Flops of the Century
Though she doesn't wear an Apple Watch, the designer said she's also interested in wearable technology. At her New York Fashion Week show in September 2012, she sent models down the runway wearing Google Glass.
But von Furstenberg cautions the term "wearable tech" will soon become obsolete.
"Wearable technology won't even be a word anymore, because everything you do will have technology," she said.
Von Furstenberg added that technology isn't just important for the future of fashion products—it's already crucial to their marketing.
"If you're interested in millennials, everyone is on social media and everyone is a brand," she said. "It's very interesting to brands to see how they can work with a generation, who each of them is [their own] brand."
This article originally appeared on CNBC.
Read more from CNBC:
For an airline upgrade, miles aren't the best
How movie theaters are striking back against Netflix
14 retailers shaking up the industry
Tax Refunds Rebound
![](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/media/120916_tax-returns-taxes.jpg?itok=BnLMqpxX)
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
![](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/articles/06052012_US_debt_article.jpg?itok=HsRxqLe6)
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
![Client Sanon has her finger pricked for a blood sugar test in the Family Van in Boston](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/media/05082015_Diabetes_Test.jpg?itok=zqK6NepO)
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
![Lumberton, North Carolina An aerial view shows a neighborhood that was flooded after Hurricane Matthew in Lumberton, North Carolina](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/slides/091116_Hurricane_Matthew2.jpg?itok=ZBjFCrcX)
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
![A growing number of patients are being denied access to newer oral chemotherapy drugs for cancer pills with annual price tags of more than $75,000.](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/articles/03222010_Pills_article.jpg?itok=QwQLvxAP)
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.